Dr Zoe Young is one of those rare creatures: an academic organisational sociologist and practising consultant to industry for the development of gender-equitable policies around the issue of flexible working. She has recently published an important research monograph, based on her PhD, exploring the experiences of flexible working among working mothers. In WAN we were very pleased that Dr Young accepted our invitation to share her interesting findings to an engaged, mixed audience of academics and professional services, with a lively discussion ensuing.
Flexible working is often mooted as the panacea for gender-based inequities in the workplace in terms of stalling and interrupted career progression and gender pay gaps. Moreover, this is primarily a gendered issue as flexible working is most likely to be requested by women, and this for the equally gendered reason that it is mostly women who are expected to adapt their working lives to the demands of childcare.
The conventional argument for flexible working (which is different from part-time working) is that this will help women to balance family and work time better and in consequence will overcome gendered career inequities. But does it?
Dr Young’s research suggests otherwise, pointing out that there are multiple variations of flexible working that could potentially be offered to employees from a currently very limited menu. Not only is the menu unimaginative and meanly populated, but while women have a legal right to request flexible work, companies are under no legal obligation to comply. Her research illustrates the unnecessary stressors and casualties caused to women workers by organisations unwilling to adapt to employees’ changing circumstances – and how flexible working, as it is currently practiced, far from being a solution, may add to the issues that disadvantage women in the workplace.
At BU the benefits of promoting flexible working is being seriously explored by the Equal Pay Review Committee and by Athena SWAN committees. It is recognised that all posts ideally should be flexible working ones and that male colleagues should also be encouraged to consider new working modes in order to spread the potential benefits. However, as Dr Young’s research suggests, a very important outcome of ensuring greater gender representation for flexible working, is that it would also serve to minimise the currently feminised disadvantages associated with that elusive pursuit of a better work-life balance.
Following a competitive bidding process, Emma Keene and Julia Karol (BSc Marketing, final year students) have been successfully awarded this year ‘staff student co-creation award’. Emma is awarded for the project’ The contour generation’ which looks into the negative impact of social media on millennial’s mental health. Emma is mentored by Samreen Ashraf.
Whereas Julia’s project, “The snob effect” looks into the impact of Instagram influencers on the consumption of luxury fashion”. Julia has worked under the supervision of Dr. Elvira Bolat.
Congratulations to both the winners!
The Secretary of State for Business, Energy and Industrial Strategy and the Minister of State for Universities, Science, Research and Innovation have commissioned Professor Sir Adrian Smith to provide independent advice on the design of future UK funding schemes for international collaboration, innovation and curiosity-driven blue-skies research. There is a written call for evidence to inform this advice, and BU is preparing an institutional response to this call.
Further information can be found in the call for evidence document, and associated Terms of Reference.
How to contribute
If you would like your feedback to be included in the institutional response, please complete the feedback form and send to Lisa Andrews, RDS Research Facilitator by Wednesday 15th May.
This week saw the successful launch of an important new partnership between Bournemouth University (BU), the local NHS, charities and industry. The aim is using innovation to drive forward improvements in healthcare outcomes for people across Dorset. This ‘Transforming Healthcare Through Innovation’ event marked the start of a formal partnership between BU and Dorset’s Integrated Care System (ICS), which is a partnership of all NHS and local authorities in the county. This partnership fits very well with BU’s Strategic Investment Area (SIA) Medical Science. The development of Medical Science is a core component of BU2025.
It was widely recognised that the social and behavioural sciences are essential to health and health care. Dr. Phil Richardson from the NHS Dorset Clinical Commissioning Group, who leads the ICS, stressed the importance of moving from a medical model of public health to a more social model. This ties in closely with sociological work on the medical/social model conducted at BU in maternity care [1-6].
Also at the launch event Dr. Caroline Ellis-Hill highlighted the importance of humanising care in a hands-on session. BU academics in have developed a philosophically-driven approach to caring, health and wellbeing based on humanising practices. The theoretical underpinning was originally developed by BU Prof. Les Todres and colleagues [7-11]. Humanising practice is supported by work settings that encourage connection to personal experience and research which privileges subjective experience and knowing; such as phenomenology, narrative, auto-ethnography, embodied knowing and arts–based approaches.
Prof. Edwin van Teijlingen
Centre for Midwifery, Maternal & Perinatal Health
- van Teijlingen E. (2005) A critical analysis of the medical model as used in the study of pregnancy and childbirth, Sociological Research Online, 10 (2)
- MacKenzie Bryers H., van Teijlingen, E. (2010) Risk, Theory, Social & Medical Models: critical analysis of the concept of risk in maternity care, Midwifery 26(5): 488-496.
- Brailey, S., Luyben, A., Firth, L, van Teijlingen, E. (2017) Women, midwives & medical model of maternity care in Switzerland, International Journal of Childbirth 7(3): 117-125.
- van Teijlingen, E. (2017) The medical and social model of childbirth, Kontakt 19(2): e73-e74
- Luce, A., Cash, M., Hundley, V., Cheyne, H., van Teijlingen, E., Angell, C. (2016) “Is it realistic?” the portrayal of pregnancy and childbirth in the media BMC Pregnancy & Childbirth 16: 40 http://bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/s12884-016-0827-x
- Taylor, A., van Teijlingen, E., Ryan, K., Alexander, J. (2019) ‘Scrutinised, judged and sabotaged’: A qualitative video diary study of first-time breastfeeding mothers, Midwifery 75: 16-23.
- Todres, L., Galvin, K.T., Holloway, I. (2009) The humanization of healthcare: A value framework for qualitative research, International Journal of Qualitative Studies on Health and Well-being, 4:2, 68-77, DOI: 10.1080/17482620802646204
- Galvin, K., Todres, L. (2013) Caring and Wellbeing. London: Routledge.
- Hemingway, A, Scammel, J., Heaslip, V. (2012) Humanising nursing care: a theoretical model. Nursing Times 108 (40) / www.nursingtimes.net
- Scammel,J ,Hemingway, A., Heaslip,V. (2012) Humanising values at the heart of nursing education. Nursing Times 108 (41)/ www.nursingtimes.net
- Scammell, J., Tait, D. (2014) Using humanising values to support care. Nursing Times 110 (15) / www.nursingtimes.net
Smart is the new name for Innovate UK’s ‘Open grant funding’ programme.
Innovate UK, as part of UK Research and Innovation, will invest up to £20 million in the best game-changing or disruptive ideas with a view to commercialisation.
All proposals must be business focused, rather than pure research. Applications can come from any area of technology (including arts, design, media or creative industries), science or engineering and be applied to any part of the economy.
Call open: 18 February 2019, Monday
Call close : 24 April 2019, Wednesday
Available funding : between £25,000 and £500,000 (for single company or collaboration); between £25,000 and £2m (for collaboration only)
Duration : between 6 and 8 months (for single company or collaboration); between 19 and 36 months (for collaboration only)
Please see this link for more information.
Innovate UK, through the UKRI’s Strategic Priorities Fund is investing up to £6million in collaborative, business led research and development (R&D) projects.
The aim of this competition is to solve industry-focused major cyber security-related challenges in the Internet of Things (IoT). You should include a plan to test nearer-to-market interventions and experiments in real environments.
Competition opens : 18 February 2019 (Monday)
Competition closes : 1 May 2019 (Wednesday; noon)
Funding available : Your project’s total eligible costs must be between £2.5 million and £4 million and you can request up to £2 million grant.
For more information, please refer to this link.
Image from tbat.co.uk
The Industrial Strategy Challenge Fund invites proposal from researchers interested in research projects to develop battery related characterisation analytical techniques and capabilities.
This call is expected to lead to new characterisation and analytical techniques which will have the effect of strengthening the UK’s leading position in electrochemical energy storage technology, providing our battery researchers with world leading methods and capabilities to advance their research. In short, we are looking for a revolution in battery research and a “business as usual” approach will not be deemed sufficient.
Closing date : 4 April 2019
Available award : £500,000 (up to £2million available for up to four awards)
Project duration : 21 months
For more information, please visit this link.
IMPORTANT : If you are planning to submit an application you must register your intent by completing the short survey at the bottom of this page by 14 March 2019 16:00.
Image from www.immerseuk.org
The UK Research and Innovation, through the Industrial Strategy Challenge Fund, is launching the Audience of the Future Challange (AofT) Investor Accelerator co-investment fund on 4 March.
This next phase of AoFT co-investment fund is aimed at supporting the commercial development of significant innovation in the UK immersive tech sector through simultaneous grant funding and venture capital investment in UK creative businesses.
How it works
- The Investor Accelerator provides simultaneous grant funding and venture capital investment for early stage projects:
- Innovate UK funds the R&D being carried out by company
- Investors invest in the company itself
- It consists of two competition stages: stage 1 for investors (opens 4 March 2019), stage 2 for companies (opens 20 May 2019)
- Up to £2m of funding is available for industrial R&D; projects’ total costs can be between £150,000 and £300,000
- The Investor Accelerator will fund up to 70% of eligible project costs in grant funding for micro or small businesses (under 50 employees) and up to 60% for medium-sized businesses (50 – 250 employees)
- Investors commit to exploring co-investment in the portfolio of companies selected in Stage 2 at 30% for SME / Micro and 40% for middle size companies
- The competition is open to single SMEs who are looking for grant funding and who want to establish an equity relationship with a UK venture capital firm. The funding on offer should help businesses move closer towards a proposition that is commercially viable.
How to apply – and key dates
Applications open | 4 March 2019 | Deadline for applications | Midday, 3 April 2019
Investors can make an application and register their interest by completing an IA Investor application form, which can be found on the Immerse UK website on Monday 4 March. Applicants must be a UK investor or an international investor with a UK office.
Don’t forget the launch date! You can contact Mairi Dillon at the KTN on firstname.lastname@example.org who will be able to send you a reminder when the fund goes live in March.
- For Creative and Tech Business
Applications open | 20 May 2019
Application forms for UK Businesses will be available on Immerse UK from 20 May. A series of briefing events will be held around the UK in May, more information will be made available from April 2019 on Immerse UK.
For more information about this funding opportunity, please visit this link.
Hunter Hines, a PhD student supervised by Dr Genoveva Esteban in the Department of Life and Environmental Sciences (SciTech), has had a piece published by the prestigious journal Nature. Hines is the first author on an article about using social media in microbiology outreach at a global scale. Hunter’s Instagram account @microbialecology currently has 55,000 followers. At the end of 2018 his account received over 1.4 million views in a single week. Around this time this also went viral being picked up by ~30 international media outlets, including National Geographic (Russia). The Nature piece published this week can be read here: doi:10.1038/d41586-019-00493-3
Hunter’s Instagram account: https://www.instagram.com/microbialecology
NatGeo Russia: http://www.nat-geo.ru/nature/1249648-snyato-cherez-mikroskop-ili-chto-proiskhodit-v-kaple-vody/
Hunter’s PhD research is on the global distribution of the single-celled organisms known as protists.
Innovate UK, part of UK Research and Innovation, has up to £5 million to invest in projects through the digital health technology catalyst – a programme that aims to accelerate the development of digital health innovations. UK businesses, partnered with other organisations including NHS organisations, HEIs, charities, public sector organisations, etc can apply for a share of up to £5 million to develop new digital health products through the Industrial Strategy Challenge Fund. The project lead will need to be a UK-based small or medium-sized business (SME).
The competition is part of the Industrial Strategy Challenge Fund to deliver leading-edge healthcare in the UK.
Call open : 11 February 2019
Deadline : 10 April 2019
Funding available : between £300,000 and £1million
Project duration : 18 months (between 1 October 2019 and 1 March 2021)
For more information about this funding call, please see this link.
ICAN: Innovate UK in the South West
Innovation, Commercialisation And Networking: Turn ideas into commercial success. Get support, get inspiration, get funded – hear from Innovate UK, Dorset LEP and invited guests.
Innovation, Commercialisation And Networking (ICAN) is an event which aims to provide inspirational and informing content for any sized business or individuals with great ideas who want to stay ahead of the game.
It is a crucial time for businesses within the UK and innovation is key to maintaining a competitive advantage. New ideas are vital for businesses but this event looks at turning these ideas into reality, how to get innovation projects funded, who to turn to for support and guidance and crucially, how to turn these ideas into commercial success.
You’ll hear from businesses who have been there and done it, put your questions to an expert innovation panel and participate in workshops tailored to specific innovation topics. In addition to all of this, the event will provide a great networking opportunity to meet like-minded businesses and professional support services.
We look forward to seeing you at Bournemouth University on the 30th January 2019.
Places are limited so follow this link
to book now!
Agenda to follow.
Biomedical Catalyst 2019 round 1: feasibility and primer awards
The aim of the Biomedical Catalyst is to support the development of innovative healthcare products, technologies and processes. This competition combines the feasibility and primer (proof of concept) strands to enable SMEs to apply for projects lasting 3 to 18 months.
The aim of this competition is to explore and evaluate the commercial potential of an innovative scientific idea or carry out a technical evaluation through to proof of concept in a model system by:
- reviewing research evidence and identifying possible applications
- assessing business opportunities
- assessing and/or protecting intellectual property
- validating initial concepts and existing pre-clinical work through experimental studies
- initial demonstration using in-vitro and in-vivo models (but not human clinical trials such as safety and efficacy)
- early stage prototyping
- preliminary regulatory advice
Competition opens : 21 January 2019 (Monday)
Competition closes : 3 April 2019 (12 noon; Wednesday)
Available funding : between £50,000 and £1,000,000
Duration : between 3 to 18 months (starts by 1 September 2019; ends by 31 March 2021)
Please this link for more details.
Biomedical Catalyst 2019 round 1: early and late stage awards
UK businesses can apply for a share of up to £7 million to explore and evaluate the commercial potential of a scientific idea to solve a healthcare challenge.
The aim of this competition is to enable companies to create a data package that can support the subsequent testing of your products or carry out evaluations in a clinical setting or other relevant environment. This can include:
- experimental evaluation (at laboratory scale)
- use of in vitro and in vivo models to evaluate proof of concept or safety
- exploring potential production mechanisms
- product development planning
- intellectual property protection
- demonstrating of clinical utility and effectiveness
- demonstrating of safety and efficacy (including phase 1 and 2 clinical trials)
- regulatory planning
Competition opens : 21 January 2019 (Monday)
Competition closes : 3 April 2019 (12 noon; Wednesday)
Available funding : between £250,000 and £4,000,000
Duration : Must be at least one year (starts by 1 September 2019; ends by 31 March 2021)
Please this link for more details.
Using drama and storytelling in dementia care: Kick-off meeting for ERASMUS+ 2018 funded project
Last week, Dr Ben Hicks, I and the European partners from Greece, Romania, Bulgaria and Ireland began the ERASMUS+ 2018 funded project, exploring drama and storytelling in dementia care. The kick-off meeting was held in Bucharest, Romania, where all partners met to discuss the implementation of the project and establish targets for the next two years.
The morning session began with a discussion regarding the process of producing a booklet “Life in a story: creative arts and storytelling use for Alzheimer’s Disease patients and carers”. This will be based on a systematic review, conducted by Bournemouth University, and interviews with professionals who use drama and storytelling as a mean to engage people with dementia. In the afternoon, representatives from The Gaiety School of Acting, Ireland, introduced us to the use of theatre and storytelling. This was by far the most creative and interesting moment from the meeting, as we passed a ball of string amongst ourselves whilst regaling the proudest moment in our life.
The ball of string went around the table and everyone got a chance to tell their story. At the end, we could tangibly see that although we were all individuals, we each had similar stories that bound us together. The partners from Gaiety School of Acting will be creating a training programme using similar methods that focus of theatre and storytelling to train health and social care professionals to better understand, engage and support people living with dementia and their care partners.
As the meeting progressed, we also discussed the preparation of a toolkit for family carers to improve communication with people with dementia as well as the policy recommendations required for creating dementia friendly communities and institutions through the use of creative arts.
The meeting went well, and clear targets and future plans were established for the project. Moving forward, Bournemouth University will now begin conducting a systematic review of the area as well as interviews with dementia practitioners. This phase of the research will conclude in April 2019 and will inform the development of a ‘Train-the-Trainer booklet that will supplement the future drama and storytelling workshops (Phase 2).
My first international meeting as a research assistant exceeded my expectations. We received a very warm welcome, tackled the workload with a lot of heated discussions and achieved positive outcomes from the meeting. It was interesting to learn about cross cultural differences in dementia care and the benefits that the creative arts can offer people with dementia and their care partners. However, it was also upsetting to listen to project partners sharing their experiences of battling their Governments to provide even the most minimal of financial support for those living with dementia. Hopefully, this ERASMUS+ 2018 project will not only bring more dementia awareness across European countries, but also enable a wide variety of people to use drama and storytelling in dementia care to improve understanding of dementia and enhance the support provided to those living with the condition. I really look forward to the practical part of this project, when we receive the training from Gaiety School of Acting.
Blog written by Irma Konovalova (Research Assistant in the ADRC).
To help us prepare for our upcoming submission to the Research Excellence Framework (REF) 2021 we are establishing a number of internal review panels to review and assess BU’s research outputs and impact case studies.
Expressions of Interest (EoI) are invited from academic staff who are interested in being a Panel Member. There will be one panel per Unit of Assessment (UOA) listed below. Those interested should identify which UOA Panel they would like to be considered for and put forward a short case (suggested length of one paragraph) as to why they are interested in the role and what they think they could bring to it. EoIs should be emailed to email@example.com by 14th December 2018.
UOA Teams would particularly welcome EoIs from those who have:
- Experience reviewing for previous REF stocktake exercises
- Experience in editorship
- Experience peer review
Full details of the role, the process of recruitment and terms of reference for the panels themselves can be found here.
Any queries regarding a specific panel should be directed to the UOA Leader. General enquiries should be directed to Shelly Anne Stringer, RKEO.
|Unit of Assessment
||Public Health, Health Services and Primary Care
||Prof. Edwin Van Teijlingen
||Allied Health Professions, Dentistry, Nursing and Pharmacy
||Psychology, Psychiatry and Neuroscience
||Dr. Peter Hills
||Computer Science and Informatics
||Prof. Hamid Bouchachia
||Prof. Zulfiqar Khan
||Geography and Environmental Studies
||Prof. Rob Britton
||Prof. Kate Welham and Prof. Holger Schutkowski
||Business and Management Studies
||Prof. Dean Patton
||Dr Sascha-Dominik Bachman
||Social Work and Social Policy
||Prof. Jonathan Parker
||Prof. Julian McDougall and Prof. Debbie Holley
||Sport and Exercise Sciences, Leisure and Tourism
||Prof. Tim Rees (Sport) Prof. Adam Blake (Tourism)
||English Language and Literature
||Prof. Bronwen Thomas
||Art and Design: History, Practice and Theory
||Prof. Jian Chang
||Music, Drama, Dance, Performing Arts, Film and Screen Studies
||Prof. Kerstin Stutterheim
||Communication, Cultural and Media Studies, Library and Information Management
||Prof. Iain MacRury
Dr Gloria Khamkar from BU’s Faculty of Media and Communication recently visited York University, Canada to meet Dr Anne F. MacLennan (Associate Professor) under the BU Acorn Funding scheme. The aim of this trip was to explore the possibility of developing a collaborative research project in the field of community radio for migrants in the UK and Canada. Gloria spent a week in Canada to work on this task. As an outcome of this trip, she is applying for the British Academy Small Research Grants 2018, which is due for the submission this week.
This proposed research project would examine the culture of radio catering to South Asian migrant communities in the UK and Canada. It will examine the changing culture of radio for the migrant communities by interrogating the surrounding questions of the existence, relevance and significance of this medium. The proposed research project focuses on ‘impact’ and is timely.
Gloria believes that it was a learning experience visiting Canada and working on this project proposal under the BU Acorn Funding scheme, and, that this support is very valuable for the early career researchers like her at BU.
We wish Gloria good luck!
If you need help with your research application and can meet certain criteria, then you may be eligible to receive support from one of our External Application Reviewers (EARs).
With a new and simplified process, you can request this when you submit your Intention to Bid form, and you meet at least one of the following conditions:
- The application is to a prestigious funder (UK research councils, Wellcome Trust, Leverhulme Trust, British Academy, Royal Society, NIHR and EU Horizon 2020)
- The application is to a strategically important funding call, including those in the BU2025 Strategic Investment Areas
- NERC Standard Grants
- One-off calls for multi-million pound bids (such as AHRC’s Creative Clusters Programme and Research England’s E3 call)
- The applicant is a member of the BU Research Council Development Scheme and is applying to a UK Research Council call
- The applicant is an ECR and is applying to a prestigious funder
Your Research Facilitator will then be in contact to discuss your needs. Approval will need to be given both by RKEO and your department before an EAR is appointed to support you.
If you do not meet the above conditions, help may still be available in certain circumstances. Additionally, certain calls may be eligible for external support from other sources. – please discuss these with your Research Facilitator.
Please note that this is an application reviewing service; the EARs will not write your bid for you.
The ItB form is a mandatory document for completion by all BU staff as part of the internal approvals process for external RKE (Research and Knowledge Exchange) funding applications.
In line with the BU2025 Strategic Plan and the latest development from the RKE development framework initiatives, the ItB form has recently gone through some additions and modifications in order to incorporate these.
Please see below details of the changes:
1. Prestigious Research Funders PDRA and PGR Studentship scheme
The BU Prestigious Research Funders PDRA and PGR Studentship scheme provides internal investment for additional research staff/students on applications for external research funding from a list of prestigious funders. The scheme was first introduced in 2017, with a recent revision conducted in October 2018. The scheme guidance can be found here. If you are eligible, you can make use of this section on the ItB form to indicate if you wish to utilise this scheme.
2. External Application Reviewers
As part of the RKE Development Framework, academics now have the opportunity to engage with external application reviewers or external trainers with the aim to enhance research funding applications prior to submission. The scheme was first introduced in 2017, with a recent revision conducted in October 2018. The scheme guidance can be found here. If you are eligible, you can make use of this section on the ItB form to indicate if you wish to utilise this scheme. Your request will then be forwarded to the relevant Research Facilitator for consideration and action.
3. BU2025 Strategic Plan
In order to track BU’s progress and development against the BU2025 Strategic Plan, three new sub-sections have now been added to the ItB form so that we can efficiently capture and record information on research projects that meet the UN Sustainable Development Goals; research projects with strong elements of Social Science and/or Humanities; and research projects that align with the BU2025 Strategic Investment Areas.
The newly revised Intention to Bid form can be found here. The ItB form is a mandatory step as part of the internal approvals process for external funding applications and it is important for all sections to be completed when this is returned to your Funding Development Officer.
If you have further queries on how to complete the form or if you need help with completing the form, please do not hesitate to get in touch with your Funding Development Officers.
The Department of Health and Human Services at the National Institutes of Health has announced a funding opportunity to provide a mechanism of support to research organizations interested in clinically translating already optimized quantitative imaging software tools capable of measuring or predicting the response of cancer to clinical therapies, or in translating imaging software tools for planning and validating radiation therapy treatment strategies in clinical trials. The proposed research effort should be an extension of the research that successfully completed the tasks of developing and optimizing the chosen software tools or data collection methods intended to facilitate clinical decision making during clinical trials.
Call opens : 5 January 2019
Call deadline : 5 February 2019
Award available : All direct costs not exceeding $500,000 each proposed year
Project duration : 5 years
Please see this link for more information.